Transplant indications, guidelines and recommendations: Caveat Emptor

• by Robert Peter Gale, Giovanni Barosi

• October 28, 2021

Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders

• by Eilidh M Duncan, Jhulia Salviano, Charalampia Kyriakou, Samantha Nier, Simone Oerlemans, Sam Salek, Kate Morgan, Katie Joyner

• May 4, 2026

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways in standard testing, leaving oncologists with diagnostic quandaries and delays to treatment.

• by

• February 24, 2026

• 4 min

CAR T cells and T cell engagers for autoimmunity—lessons from hematology

• by Sarah Kayser, Arnon Nagler

• February 23, 2026